Smoking and idiopathic pulmonary fibrosis

Pulmonary Medicine

Volumn , Issue , 2012, Pages

  Oh, Chad K ^a   Murray, Lynne A ^a   Molfino, Nestor A ^a  

^a MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIGARETTE SMOKING; DISEASE COURSE; EVIDENCE BASED MEDICINE; FIBROSING ALVEOLITIS; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG FUNCTION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SMOKING CESSATION; SURVIVAL;

EID: 84865124017     PISSN: 20901836     EISSN: 20901844     Source Type: Journal    
DOI: 10.1155/2012/808260     Document Type: Review

References (148)

1. Raghu G., Collard H. R., Egan J. J., Martinez F. J., Behr J., Brown K. K., Colby T. V., Cordier J.-F., Flaherty K. R., Lasky J. A., Lynch D. A., Ryu J. H., Swigris J. J., Wells A. U., Ancochea J., Bouros D., Carvalho C., Costabel U., Ebina M., Hansell D. M., Johkoh T., Kim D. S., King Jr. T. E., Kondoh Y., Myers J., Mller N. L., Nicholson A. G., Richeldi L., Selman M., Dudden R. F., Griss B. S., Protzko S. L., Schnemann H. J., An Official ATS/ERS/JRS/ALAT Statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management American Journal of Respiratory and Critical Care Medicine 2011 183 6 788 824
2. Raghu G., Weycker D., Edelsberg J., Bradford W. Z., Oster G., Incidence and prevalence of idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2006 174 7 810 816 (Pubitemid 44511663)
3. Taskar V. S., Coultas D. B., Is idiopathic pulmonary fibrosis an environmental disease? Proceedings of the American Thoracic Society 2006 3 4 293 298 (Pubitemid 43845405)
4. Baumgartner K. B., Samet J. M., Coultas D. B., Stidley C. A., Hunt W. C., Colby T. V., Waldron J. A., Baughman R., Davis G. S., Garcia J. G. N., Hunningshake G. W., Kallay M. C., King T. E., Krowka M. J., Rennard S. I., Ryu J. H., Sherman C. B., Smith L. J., Toews G., Winterbauer R. H., Occupational and environmental risk factors for idiopathic pulmonary fibrosis: a multicenter case-control study American Journal of Epidemiology 2000 152 4 307 315 (Pubitemid 30626724)
5. Hubbard R., Lewis S., Richards K., Johnston I., Britton J., Occupational exposure to metal or wood dust and aetiology of cryptogenic fibrosing alveolitis Lancet 1996 347 8997 284 289 (Pubitemid 26041039)
6. Steele M. P., Speer M. C., Loyd J. E., Brown K. K., Herron A., Slifer S. H., Burch L. H., Wahidi M. M., Phillips J. A., Sporn T. A., McAdams H. P., Schwarz M. I., Schwartz D. A., Clinical and pathologic features of familial interstitial pneumonia American Journal of Respiratory and Critical Care Medicine 2005 172 9 1146 1152 (Pubitemid 43066651)
7. Ryu J. H., Colby T. V., Hartman T. E., Vassallo R., Smoking-related interstitial lung diseases: a concise review European Respiratory Journal 2001 17 1 122 132 (Pubitemid 32605656)
8. King T. E. Jr., Costabel U., Cordier J.-F., DoPico G. A., DuBois R. M., Lynch D., Lynch III J. P., Myers J., Panos R., Raghu G., Schwartz D., Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS) American Journal of Respiratory and Critical Care Medicine 2000 161 2 646 664
9. Turner-Warwick M., Burrows B., Johnson A., Cryptogenic fibrosing alveolitis: clinical features and their influence on survival Thorax 1980 35 3 171 180 (Pubitemid 10131195)
10. Watters L. C., Schwarz M. I., Cherniack R. M., Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy American Review of Respiratory Disease 1987 135 3 696 704 (Pubitemid 17041608)
11. Schwartz D. A., Helmers R. A., Galvin J. R., Van Fossen D. S., Frees K. L., Dayton C. S., Burmeister L. F., Hunninghake G. W., Determinants of survival in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 1994 149 2 I 450 454 (Pubitemid 24068994)
12. Carrington C. B., Gaensler E. A., Coutu R. E., Natural history and treated course of usual and desquamative interstitial pneumonia New England Journal of Medicine 1978 298 15 801 809 (Pubitemid 8313452)
13. Johnston I. D. A., Prescott R. J., Chalmers J. C., Rudd R. M., British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management Thorax 1997 52 1 38 44 (Pubitemid 27047223)
14. Baumgartner K. B., Samet J. M., Stidley C. A., Colby T. V., Waldron J. A., Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 1997 155 1 242 248 (Pubitemid 27053171)
15. Antoniou K. M., Hansell D. M., Rubens M. B., Marten K., Desai S. R., Siafakas N. M., Nicholson A. G., Du Bois R. M., Wells A. U., Idiopathic pulmonary fibrosis: outcome in relation to smoking status American Journal of Respiratory and Critical Care Medicine 2008 177 2 190 194
16. King T. E. Jr., Tooze J. A., Schwarz M. I., Brown K. R., Cherniack R. M., Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model American Journal of Respiratory and Critical Care Medicine 2001 164 7 1171 1181 (Pubitemid 33052246)
17. Becklake M. R., Lalloo U., The healthy smoker: a phenomenon of health selection? Respiration 1990 57 3 137 144
18. Bednarek M., Gorecka D., Wielgomas J., Czajkowska-Malinowska M., Regula J., Mieszko-Filipczyk G., Jasionowicz M., Bijata-Bronisz R., Lempicka-Jastrzebska M., Czajkowski M., Przybylski G., Zielinski J., Smokers with airway obstruction are more likely to quit smoking Thorax 2006 61 10 869 873 (Pubitemid 44570307)
19. Selman M., Rojas M., Mora A. L., Pardo A., Aging and interstitial lung diseases: unraveling an old forgotten player in the pathogenesis of lung fibrosis Seminars in Respiratory and Critical Care Medicine 2010 31 5 607 617
20. MacNee W., Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2005 2 1 50 60 (Pubitemid 40562963)
21. Cottin V., Nunes H., Brillet P.-Y., Delaval P., Devouassaoux G., Tillie-Leblond I., Israel-Biet D., Court-Fortune I., Valeyre D., Cordier J.-F., Carré P., Chabot F., Chatté G., Cotmeur D., Crestani B., Dalphin J. C., Dietemann A., Gentil B., Humbert M., Lacronique J., Mairesse M., Marchand E., Reynaud-Gaubert M., Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity European Respiratory Journal 2005 26 4 586 593 (Pubitemid 41448654)
22. Meja M., Carrillo G., Rojas-Serrano J., Estrada A., Surez T., Alonso D., Barrientos E., Gaxiola M., Navarro C., Selman M., Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension Chest 2009 136 1 10 15
23. Washko G. R., Hunninghake G. M., Fernandez I. E., Nishino M., Okajima Y., Yamashiro T., Ross J. C., Estépar R. S.J., Lynch D. A., Brehm J. M., Andriole K. P., Diaz A. A., Khorasani R., D'aco K., Sciurba F. C., Silverman E. K., Hatabu H., Rosas I. O., Lung volumes and emphysema in smokers with interstitial lung abnormalities New England Journal of Medicine 2011 364 10 897 906
24. Kawabata Y., Hoshi E., Murai K., Ikeya T., Takahashi N., Saitou Y., Kurashima K., Ubukata M., Takayanagi N., Sugita H., Kanauchi S., Colby T. V., Smoking-related changes in the background lung of specimens resected for lung cancer: a semiquantitative study with correlation to postoperative course Histopathology 2008 53 6 707 714 (Pubitemid 352768716)
25. Katzenstein A. L., Mukhopadhyay S., Zanardi C., Dexter E., Clinically occult interstitial fibrosis in smokers: classification and significance of a surprisingly common finding in lobectomy specimens Human Pathology 2010 41 3 316 325
26. Harris J. M., Johnston I. D. A., Rudd R., Newman Taylor A. J., Cullinan P., Cryptogenic fibrosing alveolitis and lung cancer: the BTS study Thorax 2010 65 1 70 76
27. Gross T. J., Hunninghake G. W., Idiopathic pulmonary fibrosis New England Journal of Medicine 2001 345 7 517 525 (Pubitemid 32758505)
28. Thannickal V. J., Horowitz J. C., Evolving concepts of apoptosis in idiopathic pulmonary fibrosis Proceedings of the American Thoracic Society 2006 3 4 350 356 (Pubitemid 43845412)
29. Desmoulire A., Chaponnier C., Gabbiani G., Tissue repair, contraction, and the myofibroblast Wound Repair and Regeneration 2005 13 1 7 12 (Pubitemid 40250424)
30. Desmouliere A., Redard M., Darby I., Gabbiani G., Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar American Journal of Pathology 1995 146 1 56 66
31. Moodley Y. P., Misso N. L. A., Scaffidi A. K., Fogel-Petrovic M., McAnulty R. J., Laurent G. J., Thompson P. J., Knight D. A., Inverse effects of interleukin-6 on apoptosis of fibroblasts from pulmonary fibrosis and normal lungs American Journal of Respiratory Cell and Molecular Biology 2003 29 4 490 498 (Pubitemid 37222687)
32. Murray L. A., Argentieri R. L., Farrell F. X., Bracht M., Sheng H., Whitaker B., Beck H., Tsui P., Cochlin K., Evanoff H. L., Hogaboam C. M., Das A. M., Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGF 1, IL-13 and CCL2 International Journal of Biochemistry and Cell Biology 2008 40 10 2174 2182
33. Liu Y., Gao W., Zhang D., Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor- 1 in a coculture system Clinical and Experimental Medicine 2009 10 3 159 167
34. Carnevali S., Petruzzelli S., Longoni B., Vanacore R., Barale R., Cipollini M., Scatena F., Paggiaro P., Celi A., Giuntini C., Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts American Journal of Physiology 2003 284 6 L955 L963
35. Moodley Y. P., Caterina P., Scaffidi A. K., Misso N. L., Papadimitriou J. M., McAnulty R. J., Laurent G. J., Thompson P. J., Knight D. A., Comparison of the morphological and biochemical changes in normal human lung fibroblasts and fibroblasts derived from lungs of patients with idiopathic pulmonary fibrosis during FasL-induced apoptosis Journal of Pathology 2004 202 4 486 495 (Pubitemid 38456167)
36. Maher T. M., Wells A. U., Laurent G. J., Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms? European Respiratory Journal 2007 30 5 835 839 (Pubitemid 351194784)
37. Thiery J. P., Epithelial-mesenchymal transitions in development and pathologies Current Opinion in Cell Biology 2003 15 6 740 746 (Pubitemid 37487967)
38. Willis B. C., Borok Z., TGF- -induced EMT: mechanisms and implications for fibrotic lung disease American Journal of Physiology 2007 293 3 L525 L534
39. Valcourt U., Kowanetz M., Niimi H., Heldin C. H., Moustakas A., TGF- and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition Molecular Biology of the Cell 2005 16 4 1987 2002 (Pubitemid 40471965)
40. Kalluri R., Weinberg R. A., The basics of epithelial-mesenchymal transition Journal of Clinical Investigation 2009 119 6 1420 1428
41. Dasari V., Gallup M., Lemjabbar H., Maltseva I., McNamara N., Epithelial-mesenchymal transition in lung cancer: is tobacco the smoking gun? American Journal of Respiratory Cell and Molecular Biology 2006 35 1 3 9 (Pubitemid 43993148)
42. Zavadil J., Bttinger E. P., TGF- and epithelial-to-mesenchymal transitions Oncogene 2005 24 37 5764 5774
43. Zavadil J., Cermak L., Soto-Nieves N., Bttinger E. P., Integration of TGF- /Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition EMBO Journal 2004 23 5 1155 1165 (Pubitemid 38436879)
44. Borok Z., Danto S. I., Lubman R. L., Cao Y., Williams M. C., Crandall E. D., Modulation of T1 expression with alveolar epithelial cell phenotype in vitro American Journal of Physiology 1998 275 1 L155 L164
45. Danto S. I., Shannon J. M., Borok Z., Zabski S. M., Crandall E. D., Reversible transdifferentiation of alveolar epithelial cells American Journal of Respiratory Cell and Molecular Biology 1995 12 5 497 502
46. Torday J. S., Torres E., Rehan V. K., The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro Pediatric Pathology and Molecular Medicine 2003 22 3 189 207 (Pubitemid 36548148)
47. Kim K. K., Kugler M. C., Wolters P. J., Robillard L., Galvez M. G., Brumwell A. M., Sheppard D., Chapman H. A., Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix Proceedings of the National Academy of Sciences of the United States of America 2006 103 35 13180 13185 (Pubitemid 44338936)
48. Kalluri R., Neilson E. G., Epithelial-mesenchymal transition and its implications for fibrosis Journal of Clinical Investigation 2003 112 12 1776 1784 (Pubitemid 38063698)
49. Selgas R., Jimenez-Heffernan J., Lpez-Cabrera M., Williams J. D., Craig K. J., Von Ruhland C., Topley N., Williams G. T., On the epithelial-mesenchymal transition of mesothelial cells Kidney International 2004 66 2 866 867
50. Grnert S., Jechlinger M., Beug H., Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis Nature Reviews Molecular Cell Biology 2003 4 8 657 665 (Pubitemid 36934968)
51. Iwano M., Plieth D., Danoff T. M., Xue C., Okada H., Neilson E. G., Evidence that fibroblasts derive from epithelium during tissue fibrosis Journal of Clinical Investigation 2002 110 3 341 350 (Pubitemid 34847966)
52. Kasai H., Allen J. T., Mason R. M., Kamimura T., Zhang Z., TGF- 1 induces human alveolar epithelial to mesenchymal cell transition (EMT) Respiratory Research 2005 6, article 56
53. Willis B. C., Liebler J. M., Luby-Phelps K., Nicholson A. G., Crandall E. D., Du Bois R. M., Borok Z., Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor- 1: potential role in idiopathic pulmonary fibrosis American Journal of Pathology 2005 166 5 1321 1332 (Pubitemid 40586504)
54. Hashimoto N., Jin H., Liu T., Chensue S. W., Phan S. H., Bone marrow-derived progenitor cells in pulmonary fibrosis Journal of Clinical Investigation 2004 113 2 243 252 (Pubitemid 38544209)
55. Bucala R., Spiegel L. A., Chesney J., Hogan M., Cerami A., Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair Molecular Medicine 1994 1 1 71 81
56. Reilkoff R. A., Bucala R., Herzog E. L., Fibrocytes: emerging effector cells in chronic inflammation Nature Reviews Immunology 2011 11 6 427 435
57. Phillips R. J., Burdick M. D., Hong K., Lutz M. A., Murray L. A., Xue Y. Y., Belperio J. A., Keane M. P., Strieter R. M., Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis Journal of Clinical Investigation 2004 114 3 438 446 (Pubitemid 39071616)
58. Moeller A., Gilpin S. E., Ask K., Cox G., Cook D., Gauldie J., Margetts P. J., Farkas L., Dobranowski J., Boylan C., O'Byrne P. M., Strieter R. M., Kolb M., Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2009 179 7 588 594
59. Shao D. D., Suresh R., Vakil V., Gomer R. H., Pilling D., Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation Journal of Leukocyte Biology 2008 83 6 1323 1333 (Pubitemid 351960310)
60. Abe R., Donnelly S. C., Peng T., Bucala R., Metz C. N., Peripheral blood fibrocytes: differentiation pathway and migration to wound sites Journal of Immunology 2001 166 12 7556 7562 (Pubitemid 32525636)
61. Chesney J., Metz C., Stavitsky A. B., Bacher M., Bucala R., Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes Journal of Immunology 1998 160 1 419 425 (Pubitemid 28116757)
62. Schmidt M., Sun G., Stacey M. A., Mori L., Mattoli S., Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma Journal of Immunology 2003 171 1 380 389 (Pubitemid 36745311)
63. Abe S., Boyer C., Liu X., Fu Q. W., Kobayashi T., Fang Q., Wang X., Hashimoto M., Sharp J. G., Rennard S. I., Cells derived from the circulation contribute to the repair of lung injury American Journal of Respiratory and Critical Care Medicine 2004 170 11 1158 1163 (Pubitemid 39577372)
64. Moore B. B., Kolodsick J. E., Thannickal V. J., Cooke K., Moore T. A., Hogaboam C., Wilke C. A., Toews G. B., CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury American Journal of Pathology 2005 166 3 675 684 (Pubitemid 40315625)
65. Moore B. B., Murray L., Das A., Wilke C. A., Herrygers A. B., Toews G. B., The role of CCL12 in the recruitment of fibrocytes and lung fibrosis American Journal of Respiratory Cell and Molecular Biology 2006 35 2 175 181 (Pubitemid 44175316)
66. Gordon S., Alternative activation of macrophages Nature Reviews Immunology 2003 3 1 23 35 (Pubitemid 37328697)
67. Hancock A., Armstrong L., Gama R., Millar A., Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung American Journal of Respiratory Cell and Molecular Biology 1998 18 1 60 65 (Pubitemid 128355347)
68. Zhou Y., Murthy J. N., Zeng D., Belardinelli L., Blackburn M. R., Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis PLoS ONE 2010 5 2
69. Savill J., Apoptosis in resolution of inflammation Journal of Leukocyte Biology 1997 61 4 375 380 (Pubitemid 27219829)
70. Tiemessen M. M., Jagger A. L., Evans H. G., Van Herwijnen M. J. C., John S., Taams L. S., CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages Proceedings of the National Academy of Sciences of the United States of America 2007 104 49 19446 19451
71. Murray L. A., Rosada R., Moreira A. P., Joshi A., Kramer M. S., Hesson D. P., Argentieri R. L., Mathai S., Gulati M., Herzog E. L., Hogaboam C. M., Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages PLoS ONE 2010 5 3
72. Mathai S. K., Gulati M., Peng X., Russell T. R., Shaw A. C., Rubinowitz A. N., Murray L. A., Siner J. M., Antin-Ozerkis D. E., Montgomery R. R., Reilkoff R. A., Bucala R. J., Herzog E. L., Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype Laboratory Investigation 2010 90 6 812 823
73. Pilling D., Roife D., Wang M., Ronkainen S. D., Crawford J. R., Travis E. L., Gomer R. H., Reduction of bleomycin-induced pulmonary fibrosis by serum amyloid P Journal of Immunology 2007 179 6 4035 4044
74. Murray L. A., Chen Q., Kramer M. S., Hesson D. P., Argentieri R. L., Peng X., Gulati M., Homer R. J., Russell T., Van Rooijen N., Elias J. A., Hogaboam C. M., Herzog E. L., TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P International Journal of Biochemistry and Cell Biology 2011 43 1 154 162
75. Church D. F., Pryor W. A., Free-radical chemistry of cigarette smoke and its toxicological implications Environmental Health Perspectives 1985 64 111 126 (Pubitemid 16135783)
76. Pryor W. A., Stone K., Cross C. E., Machlin L., Packer L., Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite Annals of the New York Academy of Sciences 1993 686 12 28 (Pubitemid 23204412)
77. Barnes P. J., Shapiro S. D., Pauwels R. A., Chronic obstructive pulmonary disease: molecular and cellular mechanisms European Respiratory Journal 2003 22 4 672 688 (Pubitemid 37258549)
78. Drost E. M., Skwarski K. M., Sauleda J., Soler N., Roca J., Agusti A., MacNee W., Oxidative stress and airway inflammation in severe exacerbations of COPD Thorax 2005 60 4 293 300 (Pubitemid 40522365)
79. Kinnula V. L., Ilumets H., Myllrniemi M., Sovijrvi A., Rytil P., 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD European Respiratory Journal 2007 29 1 51 55 (Pubitemid 46091997)
80. MacNee W., Pathogenesis of chronic obstructive pulmonary disease Proceedings of the American Thoracic Society 2005 2 4 258 266 (Pubitemid 41566933)
81. Rahman I., Biswas S. K., Kode A., Oxidant and antioxidant balance in the airways and airway diseases European Journal of Pharmacology 2006 533 13 222 239 (Pubitemid 43340015)
82. Rangasamy T., Cho C. Y., Thimmulappa R. K., Zhen L., Srisuma S. S., Kensler T. W., Yamamoto M., Petrache I., Tuder R. M., Biswal S., Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice Journal of Clinical Investigation 2004 114 9 1248 1259 (Pubitemid 40385296)
83. Shapiro S. D., Ingenito E. P., The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years American Journal of Respiratory Cell and Molecular Biology 2005 32 5 367 372 (Pubitemid 40629320)
84. Chow C. K., Rylander R., Pryor W., Cigarette smoking and oxidative damage in the lung Annals of the New York Academy of Sciences 1993 686 289 298 (Pubitemid 23204434)
85. Zavitz C. C. J., Gaschler G. J., Robbins C. S., Botelho F. M., Cox P. G., Stampfli M. R., Impact of cigarette smoke on T and B cell responsiveness Cellular Immunology 2008 253 1-2 38 44
86. Fehrenbach H., Zimmermann G., Starke E., Bratu V. A., Conrad D., Yildirim A.., Fehrenbach A., Nitrogen dioxide induces apoptosis and proliferation but not emphysema in rat lungs Thorax 2007 62 5 438 446 (Pubitemid 46698395)
87. Stevenson C. S., Belvisi M. G., Preclinical animal models of asthma and chronic obstructive pulmonary disease Expert Review of Respiratory Medicine 2008 2 5 631 643
88. Cisneros-Lira J., Gaxiola M., Ramos C., Selman M., Pardo A., Cigarette smoke exposure potentiates bleomycin-induced lung fibrosis in guinea pigs American Journal of Physiology 2003 285 4 L949 L956
89. Horowitz J. C., Martinez F. J., Thannickal V. J., Mesenchymal cell fate and phenotypes in the pathogenesis of emphysema Journal of Chronic Obstructive Pulmonary Disease 2009 6 3 201 210
90. Kim H., Liu X., Kohyama T., Kobayashi T., Conner H., Abe S., Fang Q., Wen F. Q., Rennard S. I., Cigarette smoke stimulates MMP-1 production by human lung fibroblasts through the ERK1/2 pathway Journal of Chronic Obstructive Pulmonary Disease 2004 1 1 13 23
91. Ning W., Dong Y., Sun J., Li C., Matthay M. A., Feghali-Bostwick C. A., Choi A. M. K., Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-1 in human lung fibroblasts American Journal of Respiratory Cell and Molecular Biology 2007 36 4 480 490 (Pubitemid 46623007)
92. Rennard S. I., Togo S., Holz O., Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema Proceedings of the American Thoracic Society 2006 3 8 703 708 (Pubitemid 44788228)
93. Mercer B. A., Lematre V., Powell C. A., D'Armiento J., The epithelial cell in lung health and emphysema pathogenesis Current Respiratory Medicine Reviews 2006 2 2 101 142 (Pubitemid 44054832)
94. Hodge S., Hodge G., Ahern J., Jersmann H., Holmes M., Reynolds P. N., Smoking alters alveolar macrophage recognition and phagocytic ability: implications in chronic obstructive pulmonary disease American Journal of Respiratory Cell and Molecular Biology 2007 37 6 748 755 (Pubitemid 350211645)
95. Murray L. A., Knight D. A., McAlonan L., Argentieri R., Joshi A., Shaheen F., Cunningham M., Alexopolou L., Flavell R. A., Sarisky R. T., Hogaboam C. M., Deleterious role of TLR3 during hyperoxia-induced acute lung injury American Journal of Respiratory and Critical Care Medicine 2008 178 12 1227 1237
96. Cavassani K. A., Ishii M., Wen H., Schaller M. A., Lincoln P. M., Lukacs N. W., Hogaboam C. M., Kunkel S. L., TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events Journal of Experimental Medicine 2008 205 11 2609 2621
97. Korfei M., Ruppert C., Mahavadi P., Henneke I., Markart P., Koch M., Lang G., Fink L., Bohle R. M., Seeger W., Weaver T. E., Guenther A., Epithelial endoplasmic reticulum stress and apoptosis in sporadic idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2008 178 8 838 846
98. Zhang Q., Raoof M., Chen Y., Sumi Y., Sursal T., Junger W., Brohi K., Itagaki K., Hauser C. J., Circulating mitochondrial DAMPs cause inflammatory responses to injury Nature 2010 464 7285 104 107
99. Hodge S., Matthews G., Mukaro V., Ahern J., Shivam A., Hodge G., Holmes M., Jersmann H., Reynolds P. N., Cigarette smoke-induced changes to alveolar macrophage phenotype and function are improved by treatment with procysteine American Journal of Respiratory Cell and Molecular Biology 2011 44 5 673 681
100. Kelsen S. G., Duan X., Ji R., Perez O., Liu C., Merali S., Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach American Journal of Respiratory Cell and Molecular Biology 2008 38 5 541 550 (Pubitemid 351758672)
101. Grutters J. C., du Bois R. M., Genetics of fibrosing lung diseases European Respiratory Journal 2005 25 5 915 927 (Pubitemid 40667693)
102. Hodgson U., Laitinen T., Tukiainen P., Nationwide prevalence of sporadic and familial idiopathic pulmonary fibrosis: evidence of founder effect among multiplex families in Finland Thorax 2002 57 4 338 342 (Pubitemid 34298932)
103. Hodgson U., Pulkkinen V., Dixon M., Peyrard-Janvid M., Rehn M., Lahermo P., Ollikainen V., Salmenkivi K., Kinnula V., Kere J., Tukiainen P., Laitinen T., ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis American Journal of Human Genetics 2006 79 1 149 154 (Pubitemid 43927386)
104. Gumienny T. L., Brugnera E., Tosello-Trampont A. C., Kinchen J. M., Haney L. B., Nishiwaki K., Walk S. F., Nemergut M. E., Macara I. G., Francis R., Schedl T., Qin Y., Van Aelst L., Hengartner M. O., Ravichandran K. S., CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration Cell 2001 107 1 27 41 (Pubitemid 32972035)
105. Brugnera E., Haney L., Grimsley C., Lu M., Walk S. F., Tosello-Trampont A. C., Macara I. G., Madhani H., Fink G. R., Ravichandran K. S., Unconventional Rac-GEF activity is mediated through the Dock180-ELMO complex Nature Cell Biology 2002 4 8 574 582
106. DeBakker C. D., Haney L. B., Kinchen J. M., Grimsley C., Lu M., Klingele D., Hsu P. K., Chou B. K., Cheng L. C., Blangy A., Sondek J., Hengartner M. O., Wu Y. C., Ravichandran K. S., Phagocytosis of apoptotic cells is regulated by a UNC-73/TRIO-MIG-2/RhoG signaling module and armadillo repeats of CED-12/ELMO Current Biology 2004 14 24 2208 2216 (Pubitemid 40033357)
107. Pulkkinen V., Bruce S., Rintahaka J., Hodgson U., Laitinen T., Alenius H., Kinnula V. L., Myllrniemi M., Matikainen S., Kere J., ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses FASEB Journal 2010 24 4 1167 1177
108. Armanios M. Y., Chen J. J. L., Cogan J. D., Alder J. K., Ingersoll R. G., Markin C., Lawson W. E., Xie M., Vulto I., Phillips J. A., Lansdorp P. M., Greider C. W., Loyd J. E., Telomerase mutations in families with idiopathic pulmonary fibrosis New England Journal of Medicine 2007 356 13 1317 1326 (Pubitemid 46513297)
109. Tsakiri K. D., Cronkhite J. T., Kuan P. J., Xing C., Raghu G., Weissler J. C., Rosenblatt R. L., Shay J. W., Garcia C. K., Adult-onset pulmonary fibrosis caused by mutations in telomerase Proceedings of the National Academy of Sciences of the United States of America 2007 104 18 7552 7557 (Pubitemid 47185944)
110. Cronkhite J. T., Xing C., Raghu G., Chin K. M., Torres F., Rosenblatt R. L., Garcia C. K., Telomere shortening in familial and sporadic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2008 178 7 729 737
111. Alder J. K., Chen J. J. L., Lancaster L., Danoff S., Su S. C., Cogan J. D., Vulto I., Xie M., Qi X., Tuder R. M., Phillips J. A., Lansdorp P. M., Loyd J. E., Armanios M. Y., Short telomeres are a risk factor for idiopathic pulmonary fibrosis Proceedings of the National Academy of Sciences of the United States of America 2008 105 35 13051 13056
112. Diaz de Leon A., Cronkhite J. T., Katzenstein A. L., Godwin J. D., Raghu G., Glazer C. S., Rosenblatt R. L., Girod C. E., Garrity E. R., Xing C., Garcia C. K., Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations PloS ONE 2010 5 5, article e10680
113. Renzoni E., Lympany P., Sestini P., Pantelidis P., Wells A., Black C., Welsh K., Bunn C., Knight C., Foley P., Du Bois R. M., Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis Arthritis and Rheumatism 2000 43 7 1633 1640 (Pubitemid 30452485)
114. Whyte M., Hubbard R., Meliconi R., Whidborne M., Eaton V., Bingle C., Timms J., Duff G., Facchini A., Pacilli A., Fabbri M., Hall I., Britton J., Johnston I., Di Giovine F., Increased risk of fibrosing alveolitis associated with interleukin-1 receptor antagonist and tumor necrosis factor- gene polymorphisms American Journal of Respiratory and Critical Care Medicine 2000 162 2 I 755 758 (Pubitemid 30647230)
115. Freeburn R. W., Kendall H., Dobson L., Egan J., Simler N. J., Millar A. B., The 3′ untranslated region of tumor necrosis factor- is highly conserved in idiopathic pulmonary fibrosis European Cytokine Network 2001 12 1 33 38 (Pubitemid 32281186)
116. Morrison C. D., Papp A. C., Hejmanowski A. Q., Addis V. M., Prior T. W., Increased D allele frequency of the angiotensin-converting enzyme gene in pulmonary fibrosis Human Pathology 2001 32 5 521 528 (Pubitemid 32506523)
117. Pantelidis P., Fanning G. C., Wells A. U., Welsh K. I., Du Bois R. M., Analysis of tumor necrosis factor-, lymphotoxin-, tumor necrosis factor receptor II, and interleukin-6 polymorphisms in patients with idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2001 163 6 1432 1436 (Pubitemid 32506612)
118. Hutyrov B., Pantelidis P., Drbek J., rkov M., Kolek V., Lenhart K., Welsh K. I., Du Bois R. M., Petek M., Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2002 165 2 148 151 (Pubitemid 34084448)
119. Latsi P., Pantelidis P., Vassilakis D., Sato H., Welsh K. I., du Bois R. M., Analysis of IL-12 p40 subunit gene and IFN- G5644A polymorphisms in Idiopathic Pulmonary Fibrosis Respiratory Research 2003 4 6
120. Whittington H. A., Freeburn R. W., Godinho S. I. H., Egan J., Haider Y., Millar A. B., Analysis of an IL-10 polymorphism in idiopathic pulmonary fibrosis Genes and Immunity 2003 4 4 258 264 (Pubitemid 39562124)
121. Riha R. L., Yang I. A., Rabnott G. C., Tunnicliffe A. M., Fong K. M., Zimmerman P. V., Cytokine gene polymorphisms in idiopathic pulmonary fibrosis Internal Medicine Journal 2004 34 3 126 129 (Pubitemid 38509996)
122. Vasakova M., Striz I., Slavcev A., Jandova S., Dutka J., Terl M., Kolesar L., Sulc J., Correlation of IL-1alpha and IL-4 gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Scandinavian Journal of Immunology 2007 65 3 265 270 (Pubitemid 46277053)
123. Vasakova M., Striz I., Slavcev A., Jandova S., Kolesar L., Sulc J., Th1/Th2 cytokine gene polymorphisms in patients with idiopathic pulmonary fibrosis Tissue Antigens 2006 67 3 229 232 (Pubitemid 43383371)
124. Xaubet A., Marin-Arguedas A., Lario S., Ancochea J., Morell F., Ruiz-Manzano J., Rodriguez-Becerra E., Rodriguez-Arias J. M., Iigo P., Sanz S., Campistol J. M., Mullol J., Picado C., Transforming growth factor- 1 gene polymorphisms are associated with disease progression in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 2003 168 4 431 435 (Pubitemid 37046871)
125. Selman M., Lin H. M., Montao M., Jenkins A. L., Estrada A., Lin Z., Wang G., DiAngelo S. L., Guo X., Umstead T. M., Lang C. M., Pardo A., Phelps D. S., Floros J., Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis Human Genetics 2003 113 6 542 550 (Pubitemid 37383769)
126. Checa M., Ruiz V., Montao M., Velzquez-Cruz R., Selman M., Pardo A., MMP-1 polymorphisms and the risk of idiopathic pulmonary fibrosis Human Genetics 2008 124 5 465 472
127. Bournazos S., Grinfeld J., Alexander K. M., Murchison J. T., Wallace W. A., McFarlane P., Hirani N., Simpson A. J., Dransfield I., Hart S. P., Association of Fc RIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression BMC Pulmonary Medicine 2010 10, article 51
128. Xaubet A., Fu W. J., Li M., Serrano-Mollar A., Ancochea J., Molina-Molina M., Rodriguez-Becerra E., Morell F., Rodrguez-Arias J. M., Pereda J., Casanova A., Molins L., Picado C., A haplotype of cyclooxygenase-2 gene is associated with idiopathic pulmonary fibrosis Sarcoidosis Vasculitis and Diffuse Lung Diseases 2010 27 2 121 130
129. Bournazos S., Bournazou I., Murchison J. T., Wallace W. A., McFarlane P., Hirani N., Simpson A. J., Dransfield I., Hart S. P., Fc receptor IIIb (CD16b) polymorphisms are associated with susceptibility to idiopathic pulmonary fibrosis Lung 2010 188 6 475 481
130. Coward W. R., Watts K., Feghali-Bostwick C. A., Knox A., Pang L., Defective histone acetylation is responsible for the diminished expression of cyclooxygenase 2 in idiopathic pulmonary fibrosis Molecular and Cellular Biology 2009 29 15 4325 4339
131. Coward W. R., Watts K., Feghali-Bostwick C. A., Jenkins G., Pang L., Repression of IP-10 by interactions between histone deacetylation and hypermethylation in idiopathic pulmonary fibrosis Molecular and Cellular Biology 2010 30 12 2874 2886
132. Lynch D. A., Travis W. D., Mller N. L., Galvin J. R., Hansell D. M., Grenier P. A., King T. E., Idiopathic interstitial pneumonias: CT features Radiology 2005 236 1 10 21 (Pubitemid 40861695)
133. Mueller-Mang C., Grosse C., Schmid K., Stiebellehner L., Bankier A. A., What every radiologist should know about idiopathic interstitial pneumonias Radiographics 2007 27 3 595 615
134. Hunninghake G. W., Lynch D. A., Galvin J. R., Gross B. H., Mller N., Schwartz D. A., King T. E., Lynch J. P., Hegele R., Waldron J., Colby T. V., Hogg J. C., Radiologic findings are strongly associated with a pathologic diagnosis of usual interstitial pneumonia Chest 2003 124 4 1215 1223 (Pubitemid 37290029)
135. Sumikawa H., Johkoh T., Ichikado K., Taniguchi H., Kondoh Y., Fujimoto K., Tateishi U., Hiramatsu T., Inoue A., Natsag J., Ikemoto M., Mihara N., Honda O., Tomiyama N., Hamada S., Nakamura H., Mller N. L., Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients Radiology 2006 241 1 258 266 (Pubitemid 44437504)
136. Lederer D. J., Enright P. L., Kawut S. M., Hoffman E. A., Hunninghake G., Van Beek E. J. R., Austin J. H. M., Jiang R., Lovasi G. S., Barr R. G., Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study American Journal of Respiratory and Critical Care Medicine 2009 180 5 407 414
137. Washko G. R., Lynch D. A., Matsuoka S., Ross J. C., Umeoka S., Diaz A., Sciurba F. C., Hunninghake G. M., San José Estépar R., Silverman E. K., Rosas I. O., Hatabu H., Identification of early interstitial lung disease in smokers from the COPD gene study Academic Radiology 2010 17 1 48 53
138. Craig P. J., Wells A. U., Doffman S., Rassl D., Colby T. V., Hansell D. M., Du Bois R. M., Nicholson A. G., Desquamative interstitial pneumonia, respiratory bronchiolitis and their relationship to smoking Histopathology 2004 45 3 275 282 (Pubitemid 39279185)
139. Gribbin J., Hubbard R. B., Le Jeune I., Smith C. J. P., West J., Tata L. J., Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK Thorax 2006 61 11 980 985 (Pubitemid 44787169)
140. Schwartz D. A., Merchant R. K., Helmers R. A., Gilbert S. R., Dayton C. S., Hunninghake G. W., The influence of cigarette smoking on lung function in patients with idiopathic pulmonary fibrosis American Review of Respiratory Disease 1991 144 3 I 504 506
141. Regan E. A., Hokanson J. E., Murphy J. R., Make B., Lynch D. A., Beaty T. H., Curran-Everett D., Silverman E. K., Crapo J. D., Genetic epidemiology of COPD (COPDGene) study design Journal of Chronic Obstructive Pulmonary Disease 2010 7 1 32 43
142. Bjoraker J. A., Ryu J. H., Edwin M. K., Myers J. L., Tazelaar H. D., Schroeder D. R., Offord K. P., Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis American Journal of Respiratory and Critical Care Medicine 1998 157 1 199 203 (Pubitemid 28071283)
143. Martinez F. J., Idiopathic interstitial pneumonias: usual interstitial pneumonia versus nonspecific interstitial pneumonia Proceedings of the American Thoracic Society 2006 3 1 81 95
144. Walter N., Collard H. R., King T. E., Current perspectives on the treatment of idiopathic pulmonary fibrosis Proceedings of the American Thoracic Society 2006 3 4 330 338 (Pubitemid 43845410)
145. Du Bois R. M., Strategies for treating idiopathic pulmonary fibrosis Nature Reviews Drug Discovery 2010 9 2 129 140
146. InterMune, InterMune reports results of two phase 3 CAPACITY studies of pirfenidone in IPF. 2009, http://phx.corporate-ir.net/phoenix.zhtml?c=100067p= irol-newsArticleID=1251163highlight=
147. Schnemann H. J., Jaeschke R., Cook D. J., Bria W. F., El-Solh A. A., Ernst A., Fahy B. F., Gould M. K., Horan K. L., Krishnan J. A., Manthous C. A., Maurer J. R., McNicholas W. T., Oxman A. D., Rubenfeld G., Turino G. M., Guyatt G., An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations American Journal of Respiratory and Critical Care Medicine 2006 174 5 605 614 (Pubitemid 44330555)
148. Nakanishi M., Demura Y., Mizuno S., Ameshima S., Chiba Y., Miyamori I., Itoh H., Kitaichi M., Ishizaki T., Changes in HRCT findings in patients with respiratory bronchiolitis-associated interstitial lung disease after smoking cessation European Respiratory Journal 2007 29 3 453 461 (Pubitemid 46372090)